back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-05-08 Tx date 2017-05-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+25,406 vol |
25,406 | |
| Filed 2017-05-08 Tx date 2017-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-47,372.64
-4,904 vol $9.66 each |
12,892 | |
| Filed 2017-05-08 Tx date 2017-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-16,726 vol |
0 | |
| Filed 2017-05-08 Tx date 2017-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
+16,726 vol |
||
| Filed 2017-05-08 Tx date 2017-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$161,573
+16,726 vol $9.66 each |
17,796 | |
| Filed 2016-08-12 Tx date 2016-07-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-26 vol |
||
| Filed 2016-08-12 Tx date 2016-07-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-26 vol |
||
| Filed 2016-08-12 Tx date 2016-07-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-618.28
-26 vol $23.78 each |
1,070 | |
| Filed 2016-08-11 Tx date 2016-07-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,096 vol |
16,726 | |
| Filed 2016-08-11 Tx date 2016-03-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-11 Tx date 2016-07-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,096 vol |
1,096 | |
| Filed 2016-08-11 Tx date 2016-07-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-26 vol |
1,070 | |
| Filed 2016-08-11 Tx date 2016-06-17 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$408,114
+16,726 vol $24.40 each |
||
| Filed 2016-08-11 Tx date 2016-06-17 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$374,996
+16,726 vol $22.42 each |
17,822 | |
| Filed 2016-07-21 Tx date 2016-06-17 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$408,114
+16,726 vol $24.40 each |
17,822 | |
| Filed 2016-03-15 Tx date 2016-03-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-15 Tx date 2016-03-11 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Eshelman, Fredric
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$76,226
+1,096 vol $69.55 each |
1,096 |